1. Home
  2. FORD vs GNPX Comparison

FORD vs GNPX Comparison

Compare FORD & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORD
  • GNPX
  • Stock Information
  • Founded
  • FORD 1961
  • GNPX 2009
  • Country
  • FORD United States
  • GNPX United States
  • Employees
  • FORD N/A
  • GNPX N/A
  • Industry
  • FORD Plastic Products
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORD Industrials
  • GNPX Health Care
  • Exchange
  • FORD Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • FORD 8.2M
  • GNPX 6.6M
  • IPO Year
  • FORD 1995
  • GNPX 2018
  • Fundamental
  • Price
  • FORD $9.38
  • GNPX $0.31
  • Analyst Decision
  • FORD
  • GNPX
  • Analyst Count
  • FORD 0
  • GNPX 0
  • Target Price
  • FORD N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • FORD 27.2K
  • GNPX 3.5M
  • Earning Date
  • FORD 08-13-2025
  • GNPX 08-08-2025
  • Dividend Yield
  • FORD N/A
  • GNPX N/A
  • EPS Growth
  • FORD N/A
  • GNPX N/A
  • EPS
  • FORD N/A
  • GNPX N/A
  • Revenue
  • FORD $27,729,913.00
  • GNPX N/A
  • Revenue This Year
  • FORD N/A
  • GNPX N/A
  • Revenue Next Year
  • FORD N/A
  • GNPX N/A
  • P/E Ratio
  • FORD N/A
  • GNPX N/A
  • Revenue Growth
  • FORD 1.17
  • GNPX N/A
  • 52 Week Low
  • FORD $3.10
  • GNPX $0.20
  • 52 Week High
  • FORD $9.45
  • GNPX $3.97
  • Technical
  • Relative Strength Index (RSI)
  • FORD 64.68
  • GNPX 54.54
  • Support Level
  • FORD $7.61
  • GNPX $0.27
  • Resistance Level
  • FORD $8.76
  • GNPX $0.32
  • Average True Range (ATR)
  • FORD 0.75
  • GNPX 0.02
  • MACD
  • FORD 0.22
  • GNPX 0.01
  • Stochastic Oscillator
  • FORD 86.03
  • GNPX 73.00

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: